Banzel / Inovelon (Epilepsy)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 9
3 Disease Overview 11
3.1 Classification of Seizures 13
3.2 Etiology and Pathophysiology 14
3.2.1 Etiology 14
3.2.2 Pathophysiology 17
3.2.3 Prognosis 22
3.2.4 Quality of Life 23
4 Disease Management 24
4.1 Diagnosis 24
4.2 Treatment Guidelines 25
4.3 Clinical Practice 26
5 Competitive Assessment 32
5.1 Overview 32
5.2 Strategic Competitor Assessment 34
6 Banzel/Inovelon (rufinamide) 37
6.1 Overview 37
6.2 Therapeutic Role 38
6.3 Efficacy 38
6.4 Safety 38
6.5 SWOT Analysis 39
6.6 Forecast 39
7 Appendix 41
7.1 Bibliography 41
7.2 Abbreviations 42
7.3 Methodology 44
7.4 Forecasting Methodology 44
7.4.1 Prevalent Epilepsy Patients 44
7.4.2 Percent Drug-Treated Patients 45
7.4.3 General Pricing Assumptions 45
7.4.4 Individual Drug Assumptions 46
7.4.5 Generic Erosion 46
7.5 Physicians and Specialists Included in this Study 47
7.6 Primary Research – Prescriber Survey 48
7.7 About the Authors 48
7.7.1 Authors 48
7.7.2 Global Head of Healthcare 49
7.8 About GlobalData 50
7.9 Contact Us 50
7.10 Disclaimer 50